- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about CRSP
Recent news which mentions CRSP
This Analog Devices Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
February 14, 2025
From Benzinga
This Informatica Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
February 14, 2025
From Benzinga
This Roku Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday
February 14, 2025
From Benzinga
The Ultimate Healthcare Stock to Buy With $500 Right Now
February 14, 2025
From Motley Fool
Why CRISPR Therapeutics Stock Was a Massive Winner on Wednesday
February 12, 2025
From Motley Fool
Gilead Sciences, Upstart, Mercury General, Confluent And Other Big Stocks Moving Higher On Wednesday
February 12, 2025
From Benzinga
Investing $1,000 in These 3 Beaten-Down Stocks Could Be a Brilliant Move
February 10, 2025
From Motley Fool
From Motley Fool
Cathie Wood's Ark Invest Bets On Biotech With CRISPR Therapeutics Investment, Exits Roblox
January 31, 2025
From Benzinga
My Top 5 Stocks to Buy in Early 2025
January 23, 2025
From Motley Fool
Google Parent-Owned Startup To Launch AI-Designed Drug Trials By Year-End, Partnering With Eli Lilly And Novartis To Tackle Major Diseases
January 22, 2025
From Benzinga
3 Unstoppable Stocks to Buy in 2025
January 18, 2025
From Motley Fool
From Benzinga
2 Magnificent Stocks to Buy That Are Near Their 52-Week Lows
January 16, 2025
From Motley Fool
My 10 Top Stocks to Buy to Start the New Year Off Right
January 16, 2025
From Motley Fool
Meet the Innovative Growth Stock That Could Rocket 114% to 152% Higher in 2025, According to a Couple of Wall Street Analysts
January 14, 2025
From Motley Fool
3 Mid-Cap Stocks That Could Take Off in 2025
January 09, 2025
From Motley Fool
This Beaten-Down Biotech Stock Just Got Some Good News: Time to Buy?
December 22, 2024
Tickers
CRSP
From Motley Fool
2 Growth Stocks That Could Rocket Higher in 2025: Are They Right for Your Portfolio?
December 17, 2024
From Motley Fool
3 Things You Need to Know if You Buy CRISPR Therapeutics Today
December 14, 2024
Tickers
CRSP
From Motley Fool
2 Biotech Stocks to Buy Hand Over Fist in December
December 07, 2024
From Motley Fool
3 of the Best Growth Stocks You Can Buy for Less than $100
December 05, 2024
From Motley Fool
Meet the Beaten-Down Biotech Stock Cathie Wood Loves and Wall Street Says May Soar More than 65%
November 30, 2024
Tickers
CRSP
From Motley Fool
Cathie Wood Sees Tesla As 'Largest AI Project On Earth' — Here's Why She's Not Worried About Tech Investments
November 29, 2024
From Benzinga
From Benzinga
Editas Medicine Downgraded: Analyst Sees Limited Near-Term Catalysts
November 25, 2024
From Benzinga
Down 47% Since March, Is CRISPR Therapeutics Stock a Buy on the Dip?
November 24, 2024
From Motley Fool
3 Monster Stocks in the Making
November 23, 2024
From Motley Fool
2 Top Biotech Stocks to Buy Now and Hold For 5 Years or More
November 16, 2024
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.